EC Healthcare (SEHK:2138) entered into sale and purchase agreement to acquire 6.49% stake in Pangenia Inc from Sharp Point Consultant Limited for HKD 17.4 million on January 4, 2024. As of March 31, 2023, Pangenia has Net income of HKD 37.713 million. Transaction is expected to complete on February 1, 2024.

If completion does not take place by 1 February 2024 for any reason, the Purchaser shall have the right to terminate the relevant Agreement or grant an extension of the Long Stop Date by specifying a new date.